Nu-Med Plus (NUMD) Return on Equity Growth (5y) (2018 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Nu-Med Plus | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.00 |
| Sep 30, 2025 | 6.00 |
| Jun 30, 2025 | 65.00 |
| Mar 31, 2025 | -2.00 |
| Dec 31, 2024 | -3.00 |
| Sep 30, 2024 | -3.00 |
| Jun 30, 2024 | -5.00 |
| Mar 31, 2024 | -16.00 |
| Dec 31, 2023 | 11.00 |
| Sep 30, 2023 | -36.00 |
| Jun 30, 2023 | 152.00 |
| Mar 31, 2023 | -148.00 |
| Dec 31, 2022 | -63.00 |
| Sep 30, 2022 | 25.00 |
| Jun 30, 2022 | 3.00 |
| Mar 31, 2022 | 3.00 |
| Dec 31, 2021 | 8.00 |
| Sep 30, 2021 | 35.00 |
| Jun 30, 2021 | -18.00 |
| Mar 31, 2021 | -7.00 |
| Dec 31, 2020 | -6.00 |
| Sep 30, 2020 | -12.00 |
| Jun 30, 2020 | -71.00 |
| Mar 31, 2020 | 2.00 |
| Dec 31, 2019 | 3.00 |
| Sep 30, 2019 | 9.00 |
| Jun 30, 2019 | 7.00 |
| Mar 31, 2019 | 20.00 |
| Dec 31, 2018 | -11.00 |
| Sep 30, 2018 | 34.00 |
| Jun 30, 2018 | -154.00 |
| Mar 31, 2018 | 145.00 |